DOYLESTOWN, Pa. - Aprea Therapeutics, Inc. (NASDAQ: NASDAQ:APRE), a biopharmaceutical company with a market capitalization of $21.2 million focused on developing treatments targeting cancer cell ...

Detailed price information for Aprea Therapeutics Inc (APRE-Q) from The Globe and Mail including charting and trades.

"The patent represents just the first step in establishing the ... These options are exercisable at a price of $0.25 per ...

The provisional patent covers the chronic ... Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.

pharmaceutical patent policy, drug price controls and innovation. You can listen to our full discussion wherever you get your podcasts (links here) or you can visit IPWatchdog Unleashed on ...

Detailed price information for PHI Group Inc [Wy] (PHIL) from The Globe and Mail including charting and trades.

The accusation: Beijing has given national courts the power to set globally binding license fees for SEPs from EU companies "without the patent holder having to obtain its consent". This puts ...

EU Takes China to WTO Over High-Tech Patent Royalties BRUSSELS (Reuters) -The European Commission filed a complaint at the World Trade Organization on Monday against what it said was China's ...

The case concerns standard essential patents (SEPs), which protect technologies essential for the manufacture of goods that meet a certain standard, such as 5G for mobile phones. The Commission ...

With hopes of a European launch growing, Californian plant-based meat leader Impossible Foods has had a patent for its heme protein reinstated ... s soy leghemoglobin and other ingredients. This was ...

Extension of Time (EOT) Fees – The EOT fees for patent applications (other than provisional applications) will be increased in accordance with the 7.5% across-the-board fee increase. EOT fees ...

Fees for patent term extension ("PTE") applications ... (i.e., not the filing date of a provisional application to which benefit is claimed under 35 U.S.C. § 119(e)). There also is a new tiered ...